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methionine resulted in higher intracellular concentrations 
of homocysteine, which is a cosubstrate for cystathionine 
β-synthase (CBS). It seems that PPG increases CBS-medi-
ated desulfhydration by enhancing homocysteine levels in 
hepatocytes. There were no overall effects of PPG or geno-
type on intracellular or medium glutathione levels.
Keywords Cysteine dioxygenase · Taurine · 
Hypotaurine · Cystathionine · Homocysteine · Cysteine 
desulfuration
Introduction
In mammals, cysteine is catabolized by several nonoxida-
tive cysteinesulfinate-independent desulfuration pathways 
as well as by oxidative cysteinesulfinate-dependent path-
ways or it may be used for protein and glutathione synthe-
sis (Fig. 1). Cysteine is catabolized by several desulfuration 
reactions that release sulfur in a reduced oxidation state, 
generating sulfane sulfur or hydrogen sulfide (H2S), which 
can be further oxidized to sulfate. Cysteine desulfuration is 
accomplished by alternate reactions catalyzed by cystathio-
nine β-synthase (CBS), cystathionine γ-lyase (CTH), and 
3-mercaptopyruvate sulfurtransferase (MPST) (Fig. 1). The 
oxidative pathway leads to production of taurine or sulfate 
(Stipanuk and Ueki 2011).
Taurine (2-aminoethanesulfonic acid) is synthesized 
endogenously from cysteine or via conversion from 
methionine, but also provided by diet, especially fish and 
seafood. The main pathway of taurine synthesis in mam-
mals involves the oxidation of l-cysteine by the cysteine 
dioxygenase (CDO) to produce cysteine sulfinic acid. 
This acid is decarboxylated to hypotaurine by the cysteine 
sulfinic acid decarboxylase, which is finally oxidized to 
Abstract Our investigation showed that hepatocytes iso-
lated from cysteine dioxygenase knockout mice (Cdo1−/−) 
had lower levels of hypotaurine and taurine than Cdo1+/+ 
hepatocytes. Interestingly, hypotaurine accumulates in cul-
tured wild-type hepatocytes. dl-propargylglycine (PPG, 
inhibitor of cystathionine γ-lyase and H2S production) dra-
matically decreased both taurine and hypotaurine levels in 
wild-type hepatocytes compared to untreated cells. Addi-
tion of 2 mM PPG resulted in the decrease of the intracel-
lular taurine levels: from 10.25 ± 5.00 observed in control, 
to 2.53 ± 0.68 nmol/mg protein (24 h of culture) and from 
17.06 ± 9.40 to 2.43 ± 0.26 nmol/mg protein (control vs. 
PPG; 48 h). Addition of PPG reduced also intracellular 
hypotaurine levels: from 7.46 ± 3.55 to 0.31 ± 0.12 nmol/
mg protein (control vs. PPG; 24 h) and from 4.54 ± 3.20 
to 0.42 ± 0.11 nmol/mg protein (control vs. PPG; 48 h). 
The similar effects of PPG on hypotaurine and taurine lev-
els were observed in culture medium. PPG blocked hypo-
taurine/taurine synthesis in wild-type hepatocytes, suggest-
ing that it strongly inhibits cysteinesulfinate decarboxylase 
(pyridoxal 5′-phosphate-dependent enzyme) as well as 
cystathionine γ-lyase. In the presence of PPG, intracellu-
lar and medium cystathionine levels for both wild-type and 
Cdo1−/− cells were increased. Addition of homocysteine or 
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taurine by hypotaurine dehydrogenase. The conversion of 
the cysteinesulfinate to hypotaurine/taurine is minimized 
by the active transaminative catabolism of cysteinesulfinate 
to pyruvate and inorganic sulfur (Rosa et al. 2014; Stipanuk 
2004; Hayes and Sturman 1981).
Taurine is the most abundant (~millimolar concentra-
tion) free amino acid that is involved in many fundamental 
biological functions (Imae et al. 2014; Hansen et al. 2006; 
Miyazaki and Matsuzaki 2014). In liver, the most estab-
lished role of taurine is its conjugation with bile acids for 
excretion into bile (Danielsson 1963; Sjovall 1959). How-
ever, taurine has many other physiological and pharmaco-
logical roles in liver and other tissues, including stabiliza-
tion of cellular plasma membrane (Pasantes et al. 1985), 
Ca2+ transport regulation (Huxtable 1992; Schaffer et al. 
2010), osmoregulation (Nieminen et al. 1988; Huxtable 
1992; Schaffer et al. 2010), antioxidant effects (Huxtable 
1992; Nakamura et al. 1993; Schaffer et al. 2010; Rosa 
et al. 2014), anti-inflammation (Rosa et al. 2014), and 
detoxification (Huxtable 1992). Taurine supplementation 
has shown protective effects—such as antioxidant proper-
ties—to improve insulin sensitivity and dyslipidemia, as 
well as fatty liver disease, in rat models of obesity, diabe-
tes type 2, and steatohepatitis (Deminice et al. 2014; Imae 
et al. 2014; Balkan et al. 2002; Rosa et al. 2014; Xiao et al. 
2008).
In liver, taurine is abundantly maintained by endogenous 
biosynthesis and exogenous transport systems (Miyazaki 
and Matsuzaki 2014). Hepatic taurine synthesis is largely 
restricted by the low availability of cysteinesulfinate as 
substrate for cysteinesulfinate decarboxylase, and taurine 
production is increased when cysteinesulfinate increases in 
response to an increase in the hepatic cysteine concentra-
tion and the associated increase in cysteine dioxygenase 
activity (Stipanuk 2004).
Homocysteine and taurine are both sulfur-containing 
amino acids sharing the same biosynthetic pathway. As an 
end product of the transsulfuration pathway in homocyst-
eine metabolism, taurine supplementation may play a cru-
cial role in methionine metabolism in liver (Deminice et al. 
2014).
In this study, determination of taurine and hypotaurine 
levels in the primary cultures of hepatocytes partially con-
firmed previous results from the experiments performed on 
mice (Roman et al. 2013; Ueki et al. 2011), and added new 
insights to our understanding of metabolism of the studied 
metabolites. Taurine level in Cdo1−/− hepatocytes is low, 
as was observed previously in the liver of Cdo1−/− mice. 
Taurine levels in the cultured hepatocytes isolated from 
Cdo1−/− mice ranged from 4.6 to 6.2 % of the correspond-
ing wild-type levels (this study), whereas taurine levels in 
the liver of Cdo1−/− mice fed on taurine-free diets were 
found to be consistently less than 5 % of the wild-type lev-
els (previously published study). Hypotaurine level is neg-
ligible in Cdo1−/− hepatocytes as in the liver of Cdo1−/− 
mice, reflecting the block in conversion of cysteine to 
cysteinesulfinate which is a precursor in the process of 
hypotaurine/taurine synthesis.
Fig. 1  The production of 
taurine and desulfhydration 
pathways of cysteine
L-Homocysteine
Glutathione
Cystathionine β-synthase
Cysteine dioksygenase
L-Cysteine
L-Cystathionine
Serine
Methionine
Hypotaurine
Taurine
Cysteinesulfinate
H2S
S042-
S032-
Protein
Cystathionine
β-synthase
Cystathionine
γ-lyase
Cysteine aminotransferase
3-mercaptopyruvate 
sulfurtransferase
Cysteinesulfinate
decarboxylase
Sulfite
oxidase
Aspartate
aminotransferase
Sulfide quinone reductase
Sulfide dioxygenase
Sulfur transferase
Cystathionine γ-lyase
Hypotaurine
dehydrogenase
SS032-S032-
1217Effect of propargylglycine on taurine synthesis and cystathionine and homocysteine levels in hepatocytes
1 3
Interestingly, we have found in this study that signifi-
cant differences in hypotaurine and taurine levels in wild-
type hepatocytes compared to liver of wild-type mice were 
shown. We have shown that hypotaurine accumulates in 
cultured wild-type hepatocytes.
In the present study, we have also investigated the effect 
of propargylglycine (PPG; inhibitor of gamma-cystathion-
ase) on hepatic hypotaurine and taurine synthesis and the 
levels of cystathionine, total unbound homocysteine, and 
glutathione in hepatocytes isolated from wild-type and 
Cdo1 knockout male mice. Interestingly, inhibitory effects 
of PPG on hypotaurine/taurine synthesis were found in 
wild-type hepatocytes. In addition, this study proved that 
PPG, as well as homocysteine and methionine, increase 
cystathionine and homocysteine levels in the cells and in 
the conditional medium, which might result in an intensifi-
cation of desulfuration processes.
Materials and methods
Primary hepatocytes and cell culture
Cdo1-null (Cdo1−/−) and wild-type (Cdo1+/+) mice for this 
study were generated by crossing C57BL/6 Cdo1+/− male 
and female mice as described previously (Jurkowska et al. 
2014; Roman et al. 2013; Ueki et al. 2011). All experi-
mental procedures involving live animals were conducted 
with the approval of the Cornell University Institutional 
Animal Care and Use Committee (#2009-0138). Mice 
(42–100 days of age) were euthanized with an overdose of 
isoflurane, and hepatocytes were quickly isolated by Dom-
iny’s method (Dominy et al. 2012) with some modifications 
as described by Jurkowska et al. (2014). Viability of iso-
lated hepatocytes was determined by trypan blue exclusion 
and was routinely greater than 90 %.
Isolated hepatocytes were plated on collagen-coated 
6-well plates (4 × 104 cells per cm2) in DMEM (Gibco 
#12800-017, containing 1 mM pyruvate, 25 mM glucose, 
and 4 mM glutamine) supplemented with 10 % (vol/vol) 
fetal bovine serum (FBS), 100 units/ml penicillin, 100 µg/
ml streptomycin, 1 µM dexamethasone, 0.1 µM insulin, 
and an additional 1 mM sodium pyruvate and incubated at 
37 °C in an atmosphere of 5 % CO2. At 2 h after plating, 
the plating medium was replaced with fresh culture medium 
consisting of DMEM supplemented with 1 mM sodium 
pyruvate, 100 units/ml penicillin, 100 µg/ml streptomycin, 
0.2 % (vol/vol) of bovine serum albumin fraction V (instead 
of FBS), 100 nM dexamethasone, and 1 nM insulin (Sigma–
Aldrich #I9278). After 24 h, culture medium was replaced 
with treatment medium (total volume of 3.0 ml per well).
All treatment media contained 0.7 mM cyst(e)ine 
and 0.05 mM bathocuproine disulfonic acid (BCS, 
Sigma–Aldrich). 2 mM dl-propargylglycine (PPG, Sigma–
Aldrich), 0.2 mM l-homocysteine (Hcy, Sigma–Aldrich), 
or 0.5 mM l-methionine (Met, Research Products Interna-
tional, Inc) was added as indicated.
Hepatocytes were cultured in the treatment medium for 
24 and 48 h prior to harvest. For measurement of metabo-
lite levels in the medium, the medium was removed prior 
to harvesting the hepatocytes and immediately frozen and 
stored at −80 °C for later analysis. For measurement of 
metabolite levels in cells, hepatocytes were harvested by 
treating with 0.25 % trypsin (Gibco #25200), washing with 
ice-cold PBS to remove trypsin, suspending released hepat-
ocytes in ice-cold PBS, and centrifuging the cell suspen-
sion at 1600×g for 10 min at 4 °C to obtain the pelleted 
cells, which were immediately frozen and stored at −80 °C 
for later analysis.
Measurement of hypotaurine, taurine, cystathionine, 
and total unbound homocysteine and glutathione
The homogenates and media were prepared as described 
previously (Jurkowska et al. 2014). Frozen hepatocytes 
were thawed on ice and resuspended in 0.1 M phosphate 
buffer, pH 7.5, containing 2 mM tris(2-carboxyethyl)phos-
phine (TCEP) to reduce disulfide bonds linking thiols to 
protein sulfhydryl groups or to each other. The mixture 
was then sonicated for three 5 s intervals at 4 °C, and the 
homogenates were used for HPLC determinations and for 
protein level determination. Frozen samples of culture 
medium were thawed on ice, and 2 µl of 200 mM TCEP 
(in 125 mM borate buffer, pH 9.0) was added to 200 µl of 
medium to yield a final concentration of 2 mM TCEP for 
reducing disulfide bonds.
For the measurement of hypotaurine, taurine, and cysta-
thionine, the prepared homogenate or medium was mixed 
with one volume of 5 % (wt/vol) sulfosalicylic acid, and the 
mixture was centrifuged at 15,000×g for 15 min at 4 °C to 
obtain the acid supernatant. Taurine and hypotaurine were 
measured by HPLC as described previously (Ueki et al. 
2012). Samples were derivatized with o-phthaldialdehyde 
(OPA) and separated on a C18 column by gradient elution 
using 0.05 M potassium phosphate buffer (pH 7.0) −3.5 % 
(vol/vol) tetrahydrofuran mobile phase without or with 
40 % (vol/vol) acetonitrile. Detection of OPA-derivatized 
compounds was performed using excitation and emission 
peaks at 360 and 455 nm, respectively.
For the determination of total unbound glutathione and 
homocysteine, reduced homogenate or medium was mixed 
with an equal volume of 5 % (wt/vol) trichloroacetic acid, 
and the mixture was centrifuged for 15 min at 15,000×g at 
4 °C to obtain the acid supernatant. Total glutathione and 
homocysteine were measured by HPLC as described pre-
viously (Ueki et al. 2012). Briefly, thiols were derivatized 
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with 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate, and 
chromatography was carried out on a C18 reversed-phase 
column with a mobile phase of 0.1 M potassium phosphate 
buffer (pH 2.1) with 5 % (vol/vol) acetonitrile. Fluores-
cence of derivatives in the eluate was detected using an 
excitation wavelength of 385 nm and an emission wave-
length of 515 nm.
Protein assay
The protein level of cell homogenates was determined by 
the BCA Protein Assay Kit (Thermo Scientific/Pierce) 
using bovine serum albumin (BSA) as a standard.
Statistical analysis
Results were analyzed as a full factorial least squares model 
using JMP version 10 (SAS, Cary, NC). Post hoc individual 
pairwise comparisons of least squares means in the model 
were made using Tukey’s comparisons; comparisons were 
considered significant at p < 0.05. Values for hypotaurine, 
taurine, homocysteine, and glutathione were log or square 
root transformed prior to statistical analysis.
Results
In this study, the experiments were performed on hepato-
cytes isolated from wild-type and Cdo1 knockout male 
mice.
Comparison of oxidative metabolism of cysteine 
in hepatocytes isolated from wild-type and Cdo1  
knockout mice
Taurine and hypotaurine levels in cells and medium are 
reported in Figs. 2 and 3. Taurine levels ranged from 10 to 
17 nmol/mg protein in hepatocytes from Cdo1+/+ mice 
(Fig. 2), whereas hypotaurine levels ranged from 4 to 8 nmol/
mg protein in hepatocytes from wild-type mice (Fig. 3). Both 
taurine and hypotaurine levels remained very low in Cdo1−/− 
hepatocytes and in their culture medium compared to 
Cdo1+/+ hepatocytes (Figs. 2, 3). Taurine levels ranged from 
4.6 to 6.2 % of wild-type levels in hepatocytes from Cdo1−/− 
mice (Fig. 2), whereas hypotaurine levels were about 0.5 % of 
wild-type levels in hepatocytes from Cdo1−/− mice (Fig. 3).
Effect of propargylglycine on oxidative metabolism 
of cysteine in hepatocytes from wild-type mice
Addition of 2 mM PPG resulted in a dramatic reduction of 
both cellular and medium taurine levels for wild-type hepat-
ocytes, with intracellular taurine levels being about 20 % of 
the corresponding non-PPG levels and medium taurine lev-
els being about 25 % of the corresponding non-PPG levels 
(Fig. 2). Similarly, addition of 2 mM PPG reduced cellular 
and medium hypotaurine levels for wild-type hepatocytes, 
with intracellular hypotaurine levels being 3–9 % of the cor-
responding non-PPG levels and medium hypotaurine levels 
being 1–5 % of the corresponding non-PPG levels (Fig. 3). 
There was little effect of 0.5 mM Met or 0.2 mM Hcy addition 
Fig. 2  Effect of 2 mM dl-propargylglycine (PPG) on taurine levels 
in hepatocytes and in the culture medium for preparations of hepat-
ocytes from Cdo1+/+ and Cdo1−/− mice that were cultured in basal 
[0.7 mM cyst(e)ine] medium or basal medium supplemented with 
0.2 mM l-homocysteine (Hcy) or with 0.5 mM l-methionine (Met) 
for either 24 or 48 h. Results are the mean ± SEM from three inde-
pendent experiments. Statistical analysis was done using a standard 
least squares model followed by Tukey’s mean comparison proce-
dure; significance was accepted at p < 0.05. Data were log (intracel-
lular) or square root (medium) transformed before statistical analysis. 
* = +PPG value is different than the corresponding −PPG value; 
† = Cdo1−/− value is different than the corresponding Cdo1+/+ value
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on intracellular or medium taurine or hypotaurine levels, 
except for significantly higher hypotaurine levels in wild-type 
cells cultured in +Met/No PPG medium (Figs. 2, 3).
Effect of propargylglycine on cystathionine, homocysteine, 
and total glutathione levels in hepatocytes isolated 
from wild-type and Cdo1 knockout mice
Addition of PPG increased both intracellular and medium 
cystathionine levels for both wild-type and Cdo1−/− cells 
and for all culture conditions (Fig. 4). Intracellular cysta-
thionine levels in wild-type hepatocytes cultured in the 
presence of PPG were 34-times those of the correspond-
ing non-PPG values, whereas those for Cdo1−/− hepato-
cytes cultured in the presence of PPG were 14-times those 
of the corresponding non-PPG values, with the lower fold 
increases in Cdo1−/− cells being related to their higher 
basal levels of cystathionine. Medium cystathionine lev-
els in hepatocytes treated with PPG were an average of 
7.5- and 6.6-times those of the non-PPG control values for 
Fig. 3  Effect of 2 mM dl-propargylglycine (PPG) on hypotaurine 
levels in hepatocytes and in the culture medium for preparations of 
hepatocytes from male Cdo1+/+ and Cdo1−/− mice that were cultured 
in basal [0.7 mM cyst(e)ine] medium or basal medium supplemented 
with 0.2 mM l-homocysteine (Hcy) or with 0.5 mM l-methionine 
(Met) for either 24 or 48 h. Results are the mean ± SEM from three 
independent experiments. Statistical analysis was done using a stand-
ard least squares model followed by Tukey’s mean comparison pro-
cedure; significance was accepted at p < 0.05. Data were square root 
transformed before statistical analysis. * = +PPG value is different 
than the corresponding −PPG value; † = Cdo1−/− value is different 
than the corresponding Cdo1+/+ value
Fig. 4  Effect of 2 mM dl-propargylglycine (PPG) on cystathionine 
levels in hepatocytes and the culture medium for preparations of 
hepatocytes from Cdo1+/+ and Cdo1−/− mice that were cultured in 
basal [0.7 mM cyst(e)ine] medium or basal medium supplemented 
with 0.2 mM l-homocysteine (Hcy) or with 0.5 mM l-methionine 
(Met) for either 24 or 48 h. Results are the mean ± SEM from three 
independent experiments. Statistical analysis was done using a stand-
ard least squares model followed by Tukey’s mean comparison pro-
cedure; significance was accepted at p < 0.05. Data were log trans-
formed before statistical analysis. * = + PPG value is different than 
the corresponding −PPG value; # = 48 h value is different than the 
corresponding 24 h value; ╪ = +Hcy or +Met value is different than 
the corresponding basal value
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wild-type and Cdo1−/− hepatocytes, respectively. Addition 
of Met increased intracellular cystathionine levels to an 
average of 2.2-times and increased medium cystathionine 
levels to an average of 1.4-times those for cells cultured in 
basal medium. Addition of Hcy had no effect on intracel-
lular or medium cystathionine levels in cells cultured in the 
absence of PPG, but did significantly increase intracellular 
cystathionine in cells cultured with PPG (Fig. 4).
Homocysteine, which along with serine or cysteine is 
a precursor of cystathionine, was elevated in hepatocytes 
treated with 2 mM PPG (Fig. 5). Intracellular total unbound 
homocysteine levels in cells treated with PPG were an aver-
age of 3.7-times those in corresponding cells not treated 
with PPG. Levels of homocysteine in the culture medium 
were also significantly elevated (2.4-times non-PPG con-
trol values) for hepatocytes cultured in the presence of PPG 
except for those cultured in medium with added Hcy. The 
intracellular level of total unbound homocysteine increased 
over time in cells cultured in +Hcy +PPG medium, pre-
sumably due to uptake from the medium; small increases 
in medium homocysteine were observed over time in cells 
cultured in +Met medium. The intracellular level of total 
unbound homocysteine was lower for Cdo1−/− than for 
wild-type cells when hepatocytes were cultured in +Met 
+PPG medium, probably reflecting the block in transsul-
furation. Addition of Hcy or Met to the culture medium 
resulted in increase of intracellular homocysteine lev-
els on average by 3.3- or 3.5-times, respectively, for cells 
cultured in basal medium. Levels of homocysteine in the 
medium were also affected by Hcy or Met addition. Addi-
tion of Hcy to the medium dramatically increased medium 
homocysteine levels, whereas addition of Met to the 
medium resulted in an elevation of homocysteine levels to 
3.8-times basal levels for wild-type hepatocytes and 1.8-
times basal levels for Cdo1−/− hepatocytes.
Total unbound glutathione levels are shown in Fig. 6. 
There were no overall effects of PPG or genotype on 
intracellular or medium glutathione levels. Medium total 
unbound glutathione levels, but not intracellular levels, sig-
nificantly increased between 24 and 48 h of culture. Hcy 
or Met addition significantly increased intracellular glu-
tathione levels only in wild-type hepatocytes cultured in the 
presence of PPG.
Discussion
Hypotaurine accumulates in cultured wild-type hepatocytes
Despite the similarly low levels of hypotaurine and tau-
rine in cultured Cdo1−/− hepatocytes and in liver of 
Cdo1−/− mice, there were some notable differences in 
hypotaurine and taurine levels in wild-type hepatocytes 
compared to liver of wild-type mice. Interestingly, tau-
rine levels in cultured wild-type hepatocytes were sub-
stantially lower than those measured in liver of wild-type 
mice, being 10–17 nmol/mg protein in hepatocytes cul-
tured in basal medium (Fig. 2) compared to 55–80 nmol/
mg protein in liver (Roman et al. 2013; Ueki et al. 2011). 
The lower taurine levels in cultured hepatocytes sug-
gest that the whole animal may have a greater capacity 
for taurine conservation or a greater capacity for taurine 
Fig. 5  Effect of 2 mM dl-propargylglycine (PPG) on total unbound 
homocysteine levels in hepatocytes and in the culture medium 
for preparations of hepatocytes from Cdo1+/+ and Cdo1−/− mice 
that were cultured in basal [0.7 mM cyst(e)ine] medium or basal 
medium supplemented with 0.2 mM l-homocysteine (Hcy) or 
with 0.5 mM l-methionine (Met) for either 24 or 48 h. Results are 
the mean ± SEM from three independent experiments. Statistical 
analysis was done using a standard least squares model followed by 
Tukey’s mean comparison procedure; significance was accepted at 
p < 0.05. Data were square root transformed before statistical anal-
ysis. * = + PPG value is different than the corresponding −PPG 
value; † = Cdo1−/− value is different than the corresponding Cdo1+/+ 
value; # = 48 h value is different than the corresponding 24 h value; 
╪ = +Hcy or +Met value is different than the corresponding basal 
value
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synthesis than do isolated hepatocytes. A limited capac-
ity of primary hepatocytes to oxidize hypotaurine to tau-
rine may contribute to this difference because, in contrast 
to taurine levels, hypotaurine levels in cultured wild-type 
hepatocytes were higher than those in liver of wild-type 
mice, being 4–8 nmol/mg protein in cells cultured in basal 
medium (Fig. 3) compared to less than 0.8 nmol/mg pro-
tein in liver of wild-type mice. It is possible that other tis-
sues or factors in the whole animal may be necessary for 
efficient oxidation of hypotaurine to taurine. The observa-
tion of hypotaurine accumulation in cultured hepatocytes 
was unexpected but not without precedent. In most tis-
sues, hypotaurine levels are very low compared to taurine 
levels, and hypotaurine is virtually undetectable in mouse 
or rat plasma (Hirschberger et al. 1985; Nakamura et al. 
2006; Roman et al. 2013). However, very high levels of 
hypotaurine have long been known to be present in male 
reproductive tissues (i.e., epididymal fluid, seminal plasma 
and sperm) (Holmes et al. 1992; Johnson et al. 1972), and 
we recently reported very high levels of hypotaurine in 
mouse pancreas (Roman et al. 2013). The accumulation 
of hypotaurine in cultured hepatocytes follows the report 
by Vitvitsky et al. (2011) of hypotaurine accumulation 
in primary astrocytes and neurons when these cells were 
incubated with cysteamine, cysteinesulfinate, or cysteine. 
The differential accumulation of hypotaurine in different 
cell types strongly suggests that hypotaurine conversion to 
taurine is regulated. In addition, the accumulation of hypo-
taurine in the culture medium as well as in the hepatocytes 
themselves, despite a cell culture environment with 20 % 
O2, suggests that hypotaurine oxidation is enzymatically 
catalyzed. Although earlier efforts to purify and character-
ize a putative hypotaurine dehydrogenase were not suc-
cessful in identifying a protein whose activity was suf-
ficient to account for the rates of hypotaurine oxidation 
observed in vivo (Huxtable 1989; Kontra and Oja 1980; 
Oja and Kontro 1981; Sumizu 1962; Stipanuk 1986), 
the accumulation of intra- and extra-cellular hypotaurine 
in cell culture studies, as well as the very high levels of 
hypotaurine in certain tissues of whole animals, raises new 
questions about the mechanism and the location of hypo-
taurine oxidation in the body.
PPG blocks taurine synthesis by the cysteinesulfinate 
pathway
An unexpected finding was the dramatic effect of PPG 
on taurine synthesis in wild-type cells. PPG dramatically 
reduced hypotaurine and taurine levels in wild-type hepato-
cytes (Figs. 2, 3). The inhibition of hypotaurine and taurine 
production by PPG in wild-type cells, along with the low 
levels of hypotaurine and taurine in Cdo1−/− cells, suggests 
that PPG is an effective inhibitor of pyridoxal 5′-phosphate-
dependent cysteinesulfinate decarboxylase, the enzyme that 
converts cysteinesulfinate formed from cysteine by CDO to 
hypotaurine. This finding implies that use of PPG to inhibit 
CTH activity will simultaneously block the conversion of 
cysteinesulfinate to hypotaurine/taurine (Fig. 7). Although 
a loss of cysteinesulfinate decarboxylase activity should 
not affect our assessment of cysteine desulfhydration in 
hepatocytes, it would affect end points involving taurine or 
hypotaurine determinations.
Fig. 6  Effect of 2 mM dl-propargylglycine (PPG) on total unbound 
glutathione levels in hepatocytes and in the culture medium for 
preparations of hepatocytes from Cdo1+/+ and Cdo1−/− mice 
that were cultured in basal [0.7 mM cyst(e)ine] medium or basal 
medium supplemented with 0.2 mM l-homocysteine (Hcy) or 
with 0.5 mM l-methionine (Met) for either 24 or 48 h. Results are 
the mean ± SEM from three independent experiments. Statistical 
analysis was done using a standard least squares model followed 
by Tukey’s mean comparison procedure; significance was accepted 
at p < 0.05. Data for medium glutathionine levels were square root 
transformed before statistical analysis. # = 48 h value is different 
than the corresponding 24 h value; ╪ = + Hcy or +Met value is dif-
ferent than the corresponding basal value
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PPG increases CBS-mediated desulfhydration 
by enhancing homocysteine levels in hepatocytes
Genotype did not have a consistent effect on intracellu-
lar homocysteine levels (Fig. 5), similarly to our previ-
ous observations for liver of Cdo1−/− and wild-type mice 
(Roman et al. 2013). Hcy and Met were added in an effort 
to increase cosubstrate for CBS-catalyzed desulfhydra-
tion and to increase levels of S-adenosylmethionine as 
an activator of CBS (Singh et al. 2009; Finkelstein et al. 
1975). Thus, addition of Hcy or Met resulted in higher 
intracellular concentrations of homocysteine (Fig. 5), 
which is a cosubstrate for CBS-catalyzed transsulfura-
tion (Ser + Hcy → Cystathionine + H2O) and for CBS-
catalyzed cysteine desulfhydration (Cys + Hcy → Cysta-
thionine + H2S). Consequently, addition of Met results 
in increasing the intracellular and medium cystathionine 
levels (Fig. 4). This confirms our earlier results that accu-
mulation of cystathionine in Cdo1-null hepatocytes com-
pared to wild-type hepatocytes supports an important role 
of CBS in cysteine desulfhydration in liver (Jurkowska 
et al. 2014).
PPG treatment of wild-type hepatocytes increased intra-
cellular homocysteine (Fig. 5) and cystathionine (Fig. 4) 
levels. Also, we previously showed that PPG increased 
cysteine levels in hepatocytes from wild-type mice 
(Jurkowska et al. 2014). This seems to suggest that PPG, by 
raising cystathionine and homocysteine levels in the face of 
a block in CTH activity, might increase CBS-mediated des-
ulfhydration (Fig. 7).
Total unbound glutathione levels were not affected by 
PPG treatment in cultured hepatocytes (Fig. 6). As was 
reported previously, hepatic GSH concentration was also 
not decreased by the addition of PPG to the various diets 
in rats (Cresenzi et al. 2003). This may be explained by the 
observation that hepatic GSH concentration remains rela-
tively constant when cysteine concentration is >0.04 µmol/g 
(Stipanuk et al. 2002) and also by the higher priority of 
GSH synthesis than cysteine catabolic pathways for cysteine 
when its supply is limited (Stipanuk et al. 1992).
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